GSK

Bio & Pharma ABL Bio lands $2.8 billion license-out deal with GSK

ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-bas...

Bio & Pharma Korea's Samsung Biologics signs $296 mn CMO deal with GSK

South Korea’s Samsung Biologics Co. has signed a $296.1 million deal to supply biopharmaceutical products to UK-based multinational pharma gia...

Korea Investment buys US office buildings of eBay and GSK for $260 mn

Korea Investment & Securities Co. Ltd. has bought a Silicon Valley campus of eBay Inc. for 140 billion won ($130 million), shortly after closing t...